This inventor holds 1 USPTO granted patent. Top assignee: Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.. Active years: 1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1982
Title: Ilona Simonidesz Nee Vermes: Innovator in Pharmaceutical Technology
Introduction
Ilona Simonidesz Nee Vermes is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of stabilized, prostaglandin-containing tablets. Her innovative work has the potential to enhance local therapeutic applications.
Latest Patents
Ilona holds a patent for her invention titled "Stabilized, prostaglandin-containing tablets with controlled rate of solubility." This invention relates to tablets designed for local use, which contain a specific formulation of natural or synthetic prostaglandins. The tablets comprise 0.2 to 20% by weight of prostaglandins, along with various other components such as non-toxic buffers, stearic acid, lactose, and disintegrating agents. The preparation process involves applying pressure between 500 to 2000 kp/cm², ensuring the tablets maintain their stability and effectiveness.
Career Highlights
Ilona is currently associated with Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., a prominent pharmaceutical company in Hungary. Her work at this company has allowed her to focus on innovative drug formulations and contribute to advancements in the pharmaceutical industry.
Collaborations
Throughout her career, Ilona has collaborated with esteemed colleagues such as Agoston David and Tibor Horvath. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical research.
Conclusion
Ilona Simonidesz Nee Vermes is a pioneering inventor whose work in pharmaceutical technology has the potential to impact local therapeutic practices significantly. Her innovative approach to drug formulation exemplifies the importance of research and development in the healthcare sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile